150 related articles for article (PubMed ID: 36708218)
1. Lappaol F regulates the cell cycle by activating CDKN1C/p57 in human colorectal cancer cells.
Yang RY; Tan JY; Liu Z; Shen XL; Hu YJ
Pharm Biol; 2023 Dec; 61(1):337-344. PubMed ID: 36708218
[TBL] [Abstract][Full Text] [Related]
2. Lappaol F, an anticancer agent, inhibits YAP via transcriptional and post-translational regulation.
Li X; Lin YY; Tan JY; Liu KL; Shen XL; Hu YJ; Yang RY
Pharm Biol; 2021 Dec; 59(1):619-628. PubMed ID: 34010589
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.
Sun K; Wang W; Zeng JJ; Wu CT; Lei ST; Li GX
Acta Pharmacol Sin; 2011 Mar; 32(3):375-84. PubMed ID: 21278784
[TBL] [Abstract][Full Text] [Related]
4. [MicroRNA-221 controls CDKN1C/P57 expression in human colorectal carcinoma].
Sun K; Zeng JJ; Wang W; Wu CT; Lei ST; Li GX
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Apr; 14(4):279-83. PubMed ID: 21538272
[TBL] [Abstract][Full Text] [Related]
5. Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells.
Park YL; Ha SY; Park SY; Choi JH; Jung MW; Myung DS; Kim HS; Joo YE
Int J Oncol; 2019 May; 54(5):1875-1883. PubMed ID: 30864676
[TBL] [Abstract][Full Text] [Related]
6. CDKN1C/P57 is regulated by the Notch target gene Hes1 and induces senescence in human hepatocellular carcinoma.
Giovannini C; Gramantieri L; Minguzzi M; Fornari F; Chieco P; Grazi GL; Bolondi L
Am J Pathol; 2012 Aug; 181(2):413-22. PubMed ID: 22705236
[TBL] [Abstract][Full Text] [Related]
7. Lappaol F, a novel anticancer agent isolated from plant arctium Lappa L.
Sun Q; Liu K; Shen X; Jin W; Jiang L; Sheikh MS; Hu Y; Huang Y
Mol Cancer Ther; 2014 Jan; 13(1):49-59. PubMed ID: 24222662
[TBL] [Abstract][Full Text] [Related]
8. CDKN1C (P57): one of the determinants of human endometrial stromal cell decidualization.
Wang L; Yang H; Hu L; Hu D; Ma S; Sun X; Jiang L; Song J; Ji L; Masau JF; Zhang H; Qian K
Biol Reprod; 2018 Mar; 98(3):277-285. PubMed ID: 29325014
[TBL] [Abstract][Full Text] [Related]
9. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
[TBL] [Abstract][Full Text] [Related]
10. [MicroRNA-221 promotes colon carcinoma cell proliferation in vitro by inhibiting CDKN1C/p57 expression].
Sun K; Wang W; Lei ST; Wu CT; Li GX
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1885-9. PubMed ID: 22126772
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
[TBL] [Abstract][Full Text] [Related]
12. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
13. Downregulated LINC00628 aggravates the progression of colorectal cancer via inhibiting p57 level.
Zhang MC; Zhang L; Zhang MQ; Yang GX; Wang FZ; Ding P
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1763-1770. PubMed ID: 32141544
[TBL] [Abstract][Full Text] [Related]
14. TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
[TBL] [Abstract][Full Text] [Related]
15. KLF15 Inhibits Cell Proliferation in Gastric Cancer Cells via Up-Regulating CDKN1A/p21 and CDKN1C/p57 Expression.
Sun C; Ma P; Wang Y; Liu W; Chen Q; Pan Y; Zhao C; Qian Y; Liu J; Li W; Shu Y
Dig Dis Sci; 2017 Jun; 62(6):1518-1526. PubMed ID: 28421457
[TBL] [Abstract][Full Text] [Related]
16. The hallmarks of CDKN1C (p57, KIP2) in cancer.
Kavanagh E; Joseph B
Biochim Biophys Acta; 2011 Aug; 1816(1):50-6. PubMed ID: 21447370
[TBL] [Abstract][Full Text] [Related]
17.
Long ZH; Bai ZG; Song JN; Zheng Z; Li J; Zhang J; Cai J; Yao HW; Wang J; Yang YC; Yin J; Zhang ZT
Anticancer Res; 2017 Aug; 37(8):4345-4352. PubMed ID: 28739727
[TBL] [Abstract][Full Text] [Related]
18. A Beckwith-Wiedemann-Associated
Stampone E; Bencivenga D; Barone C; Di Finizio M; Della Ragione F; Borriello A
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299047
[TBL] [Abstract][Full Text] [Related]
19. S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16 expression.
Xu SY; Wang F; Wei G; Wang B; Yang JY; Huang YZ; Zhang L; Zheng F; Guo LY; Wang JN; Tang JM
Cancer Gene Ther; 2013 Dec; 20(12):690-4. PubMed ID: 24336114
[TBL] [Abstract][Full Text] [Related]
20. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
